0001013606-18-000021.txt : 20180301 0001013606-18-000021.hdr.sgml : 20180301 20180301165603 ACCESSION NUMBER: 0001013606-18-000021 CONFORMED SUBMISSION TYPE: 4/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20171030 FILED AS OF DATE: 20180301 DATE AS OF CHANGE: 20180301 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Onopchenko John CENTRAL INDEX KEY: 0001403100 FILING VALUES: FORM TYPE: 4/A SEC ACT: 1934 Act SEC FILE NUMBER: 000-28440 FILM NUMBER: 18658396 MAIL ADDRESS: STREET 1: C/O VOLCANO CORPORATION STREET 2: 11455 EL CAMINO REAL, SUITE 460 CITY: SAN DIEGO STATE: CA ZIP: 92130 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ENDOLOGIX INC /DE/ CENTRAL INDEX KEY: 0001013606 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 680328265 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2 MUSICK CITY: IRVINE STATE: CA ZIP: 92618 BUSINESS PHONE: 9495957200 MAIL ADDRESS: STREET 1: 2 MUSICK CITY: IRVINE STATE: CA ZIP: 92618 FORMER COMPANY: FORMER CONFORMED NAME: RADIANCE MEDICAL SYSTEMS INC /DE/ DATE OF NAME CHANGE: 19990122 FORMER COMPANY: FORMER CONFORMED NAME: CARDIOVASCULAR DYNAMICS INC DATE OF NAME CHANGE: 19960506 4/A 1 wf-form4a_151994134371578.xml FORM 4/A X0306 4/A 2017-10-30 2017-11-01 0 0001013606 ENDOLOGIX INC /DE/ ELGX 0001403100 Onopchenko John 2 MUSICK IRVINE CA 92618 0 1 0 0 Chief Operating Officer Common Shares 2017-10-30 4 A 0 56604 0 A 56604 D Option to Purchase 5.3 2017-10-30 4 A 0 190353 5.30 A 2018-10-30 2027-10-30 Common Shares 190353.0 190353 D Performance restricted stock unit award. Twenty-five percent of the options shall vest upon one year of service and the remaining balance will vest in equal monthly installments thereafter. On November 1, 2017, the reporting person filed a Form 4 which inadvertently reported that he acquired an option to purchase 187,464 shares of the issuer's common stock. In fact, as reported in this amendment, the reporting person acquired an option to purchase 190,353 shares of the issuer's common stock, as originally approved by the issuer's board of directors. John Onopchenko by Timothy N. Brady Attorney-in-Fact for Reporting Person 2018-03-01